In the ever-evolving landscape of transplant medicine, the challenge of optimizing immunosuppressive therapy remains pivotal for patient outcomes. A groundbreaking phase 2 randomized clinical trial,...
In a groundbreaking advance for thyroid cancer research, scientists have successfully delineated two distinct molecular subtypes of thyroid carcinoma using a comprehensive multi-omics approach. This...
In recent years, the ubiquity of synthetic chemicals in our food supply has emerged as a pressing concern within the scientific community and public health...
In a groundbreaking study published in BioMedical Engineering OnLine, researchers have unveiled compelling evidence supporting the superiority of concurrent chemoradiotherapy (CCRT) over sequential chemoradiotherapy (SCRT)...
A groundbreaking study published in BMC Cancer unveils a promising therapeutic advancement for elderly patients suffering from unresectable hepatocellular carcinoma (uHCC), a formidable liver cancer...
Researchers at Weill Cornell Medicine have uncovered a groundbreaking mechanism by which Plasmodium falciparum, the parasite responsible for the deadliest form of malaria, evades the...
In a groundbreaking exploration into the early genetic underpinnings of autoimmune diseases, researchers have unveiled complex age-dependent gene expression trajectories in young children predisposed to...
In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a phase 2 clinical trial investigating...
In a groundbreaking development that could reshape the landscape of hemorrhagic fever research and vaccine development, scientists have uncovered the pivotal role of a mucin-like...
In the high-stakes arena of liver cancer surgery, the ability to predict post-operative complications is not just advantageous—it can be life-saving. A groundbreaking prospective study...
In the relentless battle against gliomas, a notoriously aggressive and often deadly form of brain cancer, the quest for effective immunotherapy targets remains a paramount...
In a groundbreaking study published in BMC Cancer, researchers have unveiled compelling evidence positioning E2F transcription factor 2 (E2F2) as a promising therapeutic target for...
In a groundbreaking study that could redefine the future of regenerative medicine and blood disorder treatments, researchers from the Josep Carreras Leukaemia Research Institute have...
In a groundbreaking study published in Genes and Immunity in 2025, researchers led by Xu, Guo, and Ning have delivered an unprecedented comprehensive analysis of...
In recent years, the field of oncology has witnessed a surge of interest in the intricate relationship between autophagy and oncogenic RAS-driven cancers. The latest...
